Carcinoid Syndrome: The Combined Use of Ketanserin and Octreotide in the Management of an Acute Crisis during Anaesthesia
Open Access
- 1 August 1989
- journal article
- research article
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 17 (3) , 367-370
- https://doi.org/10.1177/0310057x8901700324
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Somatostatin.BMJ, 1987
- Potential role of somatostatin analogues in the treatment of cancerEuropean Journal of Clinical Investigation, 1987
- Somatostatin, anaesthesia, and the carcinoid syndrome.Anaesthesia, 1987
- Adrenergic control of serotonin release from carcinoid tumor cells in vitro and in vivoJournal of Surgical Research, 1987
- Peri–operative management of carcinoid syndrome using ketanserinAnaesthesia, 1986
- Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administrationEuropean Journal of Clinical Pharmacology, 1986
- Influence of ketanserin pretreatment on the haemodynamic responses to sternotomyAnaesthesia, 1986
- Ketanserin versus Placebo in Carcinoid Syndrome: A Clinical Controlled TrialScandinavian Journal of Gastroenterology, 1986
- Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5‐HT2) receptorArthritis & Rheumatism, 1984
- EFFICACY OF SOMATOSTATIN IN A PATIENT WITH CARCINOID SYNDROMEThe Lancet, 1978